Future Capital invests in companies engaged in the life sciences and chemistry, including nanotechnology and material sciences. The fund was founded in March 1999 at the initiative of the Hessen State Government and Hoechst AG (now Sanofi Group) and acts as an independent venture. Future Capital AG manages assets of € 51 million and invests € 0.75 to 10 million per company.
Focus Areas
Investment Types
Notable Investments
